Second Annual Regional BioTech Forum Brings Industry, Academia and Government Together
Monday, April 18, 2016
More than 700 leaders from life science companies, academic institutions, nonprofit organizations, investment funds and government entities across Maryland, Virginia and Washington, D.C. (MD-VA-DC) will convene for the second annual Regional BioTech Forum. The event will showcase the region’s biotechnology accomplishments and its commitment to advancing cutting-edge research in the MD-VA-DC corridor. Notable speakers will include: Dr. Francis Collins, Director, National Institutes of Health; Maryland Governor Larry Hogan; Virginia Governor Terry McAuliffe; and Congressman John Delaney.
“This year’s Forum builds upon the collaborative energy between industry leaders and scientists in the MD-VA-DC region to foster local growth of a diverse biotech sector dedicated to developing medicines and technologies that improve people’s health and lives”
The Forum, hosted by AstraZeneca and its global biologics research and development arm, MedImmune, in partnership with BioHealth Innovation, Inc. (BHI), the Tech Council of Maryland, Inc. (TCM), GlycoMimetics, Inc. and Virginia Bio, is held at MedImmune’s corporate headquarters in Gaithersburg. The program builds on a collective effort established last year to grow the region’s biotech ecosystem and help it to become one of the top three biotech hubs in the nation by 2023.
The two-day event explores the region’s progress toward the 2023 top biotech hub vision, examine local efforts to boost the life science industry, discuss effective models for driving innovation and highlight successful public-private partnerships, focused on addressing unmet patient needs. It will also feature panel sessions on four areas critical to the biotech industry’s growth and success – the National Institutes of Health and allied foundations; academic research and scientific initiatives; our regional talent; and investment from the financial sector.
Other key participants include:
• Dr. Stephanie Devaney, Project Manager, Precision Medicine Initiative, Office of the Chief of Staff at the White House
• Six university presidents representing Johns Hopkins, the University System of Maryland, Virginia Tech, The George Washington University and George Mason
• Dr. Bahija Jallal, Executive Vice President, AstraZeneca and Head of MedImmune
• Dr. Vikram Bajaj, Chief Scientific Officer, Verily (formerly Google Life Sciences)
• Dr. Ray Johnson, Business and Technology Executive; Former Senior Vice President and Chief Technology Officer, Lockheed Martin
“This year’s Forum builds upon the collaborative energy between industry leaders and scientists in the MD-VA-DC region to foster local growth of a diverse biotech sector dedicated to developing medicines and technologies that improve people’s health and lives,” said Bahija Jallal, Executive Vice President, AstraZeneca and Head of MedImmune. “World-class research, academic and life science organizations in our region bring the critical mass of talent and technology that will make the MD-VA-DC corridor one of the country’s top three biotech clusters by 2023.”